During the past decade, Parexel Early Phase Unit at Glendale conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parexel Early Phase Unit at Glendale" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Taisho Pharmaceutical R&D Inc." with 4 trials sponsored, "Astellas Pharma Europe B.V." with 1 trials sponsored, "PMV Pharmaceuticals, Inc" with 1 trials sponsored and "VistaGen Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parexel Early Phase Unit at Glendale" #1 collaborator was "Parexel" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Parexel Early Phase Unit at Glendale" are "Healthy Volunteers" (6 trials), "Healthy" (5 trials), "Alzheimer's Disease" (3 trials), "Psoriasis" (2 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Parexel Early Phase Unit at Glendale" in a lesser frequency.

Most popular intervention types in "Parexel Early Phase Unit at Glendale" are "Drug" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Placebo IV" (2 trials), "Placebo SC" (2 trials), "Solanezumab" (2 trials) and "TS-134" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parexel Early Phase Unit at Glendale" are 19 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Parexel Early Phase Unit at Glendale". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Parexel Early Phase Unit at Glendale, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Parexel Early Phase Unit at Glendale, 16 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".